UrSure makes urine tests to help doctors and patients improve medication adherence. We are initially focused on drugs to prevent and treat HIV infections.
We have received over $2M in funding including winning the Harvard Business School's New Venture Competition and the Harvard President's Innovation Challenge as well as a Phase I and II SBIR from the NIH. We are currently working to scale up our lab based test, which is commercialized and on the market while we complete development of our Point of Care test which will be ready for use in research studies in 2019.